Porsche and Lockheed Martin-backed lidar sensor technology developer Aeva will get the funding once its reverse merger with InterPrivate Acquisition Corp closes.

Bristol Myers Squibb participated in a series B round for the oncology drug developer that pushed its overall funding to $168m.

The corporate will get a majority stake in end-to-end construction services provider Katerra, helping it avoid bankruptcy protection.

AES and Siemens' joint energy storage venture is valued at a little over $1bn in the Qatar Investment Authority-funded transaction.

Meituan Dianping and New Hope Group have both thrown their backing behind a round topping $100m for production automation robot developer Flexiv.

Investors have thrown their backing behind a round topping $100m for Stanford-linked production automation robot developer Flexiv.

The intelligent chipmaker, which counts Microsoft, Samsung, BMW, Robert Bosch and Dell as investors, secured series E funding at a $2.77bn valuation.

The Archermind-backed operating system developer was reportedly valued at $734m valuation in a $168m round led by Beijing E-Town.

Bojia Capital reinvested in the Tencent-backed online arts education provider in a round that pushed its overall funding to $305m.

Lilly Asia Ventures has put more funding into Transcenta to help sustain the antibody drug developer's clinical-stage pipeline.